Paydirt
MZ
Insider

Martine Zimmermann

Director · Ligand Pharmaceuticals

Martine Zimmermann (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $342K of LGND (1,200 sh × $285.00, as filed), executed Sep 10. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$342K
shares × price, as filed
Last traded
Sep 10
Filed Sep 14

Median ADV $104.4M across their filed names

Open performance→
Volume by month
$342K$171K$0Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026 · sells $342K
Buys $0 Sells $342K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
LGND Ligand Pharmaceuticals Incorporated LGND · 0 buys · 1 sell 1 filing
Recent filings
LGNDSALE Ligand Pharmaceuticals Incorporated View filing → $342K
1,200 sh × $285.00
Exec Sep 10
Filed Sep 14 · 4:59 PM ET